GOALS OF WORK: We aimed to develop an instrument to assess cancer-treatment-related adverse effects that parents believe children find most bothersome and use it to solicit the opinions of parents regarding this issue. MATERIALS AND METHODS: Parents of children 4 to 18 years of age who had received intravenous antineoplastic therapy in the last month were asked to rank prevalence, severity, and degree of bother of each symptom on behalf of their child using a questionnaire. MAIN RESULTS: One hundred fifty-eight of 200 (82%) questionnaires were evaluable. The most prevalent symptoms identified were mood swings (85%), fatigue (80%), and disappointment at missing activities with friends/peers (74%). These symptoms were also most commonly identified as being significantly severe. Symptoms most commonly identified as the most bothersome were disappointment at missing activities with friends/peers (50%) and feeling worried about receiving treatment, procedures, or side effects (43%). Symptoms most commonly identified as the most severe and bothersome were disappointment at missing activities with friend/peers (46%); feeling worried about receiving treatment, procedures, or side effects (40%); and painful, aching, or stiff bones, joints, or muscles (36%). CONCLUSIONS: This information can be used when explaining the effects of cancer treatment to patients/families, creating policies regarding pediatric cancer care and framing research hypotheses in pediatric supportive care.
GOALS OF WORK: We aimed to develop an instrument to assess cancer-treatment-related adverse effects that parents believe children find most bothersome and use it to solicit the opinions of parents regarding this issue. MATERIALS AND METHODS: Parents of children 4 to 18 years of age who had received intravenous antineoplastic therapy in the last month were asked to rank prevalence, severity, and degree of bother of each symptom on behalf of their child using a questionnaire. MAIN RESULTS: One hundred fifty-eight of 200 (82%) questionnaires were evaluable. The most prevalent symptoms identified were mood swings (85%), fatigue (80%), and disappointment at missing activities with friends/peers (74%). These symptoms were also most commonly identified as being significantly severe. Symptoms most commonly identified as the most bothersome were disappointment at missing activities with friends/peers (50%) and feeling worried about receiving treatment, procedures, or side effects (43%). Symptoms most commonly identified as the most severe and bothersome were disappointment at missing activities with friend/peers (46%); feeling worried about receiving treatment, procedures, or side effects (40%); and painful, aching, or stiff bones, joints, or muscles (36%). CONCLUSIONS: This information can be used when explaining the effects of cancer treatment to patients/families, creating policies regarding pediatric cancer care and framing research hypotheses in pediatric supportive care.
Authors: John J Collins; Tom D Devine; Gina S Dick; Elizabeth A Johnson; Henry A Kilham; C Ross Pinkerton; M M Stevens; Howard T Thaler; Russell K Portenoy Journal: J Pain Symptom Manage Date: 2002-01 Impact factor: 3.612
Authors: J J Collins; M E Byrnes; I J Dunkel; J Lapin; T Nadel; H T Thaler; T Polyak; B Rapkin; R K Portenoy Journal: J Pain Symptom Manage Date: 2000-05 Impact factor: 3.612
Authors: David H Henry; Hema N Viswanathan; Eric P Elkin; Shana Traina; Shawn Wade; David Cella Journal: Support Care Cancer Date: 2008-01-17 Impact factor: 3.603
Authors: Jordanka Kirkova; Mellar P Davis; Declan Walsh; Eoin Tiernan; Norma O'Leary; Susan B LeGrand; Ruth L Lagman; K Mitchell Russell Journal: J Clin Oncol Date: 2006-03-20 Impact factor: 44.544
Authors: Deborah Tomlinson; L Lee Dupuis; Paul Gibson; Donna L Johnston; Carol Portwine; Christina Baggott; Sue Zupanec; Julie Watson; Brenda Spiegler; Susan Kuczynski; Gail Macartney; Lillian Sung Journal: Support Care Cancer Date: 2013-08-31 Impact factor: 3.603
Authors: Priya Patel; Sara R Lavoratore; Jacqueline Flank; Meaghan Kemp; Ashlee Vennettilli; Helen Vol; Tracey Taylor; Elyse Zelunka; Anne Marie Maloney; Paul C Nathan; L Lee Dupuis Journal: Support Care Cancer Date: 2019-06-08 Impact factor: 3.603
Authors: D Tomlinson; L Tigelaar; S Hyslop; T Lazor; L L Dupuis; K Griener; J Oliveria; L Sung Journal: Support Care Cancer Date: 2017-05-12 Impact factor: 3.603
Authors: Lisa Nijland; Pia Schmidt; Michael Frosch; Julia Wager; Bettina Hübner-Möhler; Ross Drake; Boris Zernikow Journal: Support Care Cancer Date: 2018-07-28 Impact factor: 3.603
Authors: Priya Patel; Paula D Robinson; Andrea Orsey; Jason L Freedman; Anne-Marie Langevin; Debbie Woods; Lillian Sung; L Lee Dupuis Journal: Pediatr Blood Cancer Date: 2016-01-27 Impact factor: 3.167
Authors: Lillian Sung; Theo Zaoutis; Nicole J Ullrich; Donna Johnston; Lee Dupuis; Elena Ladas Journal: Pediatr Blood Cancer Date: 2012-12-19 Impact factor: 3.167
Authors: Helen Vol; Jacqueline Flank; Sara R Lavoratore; Paul C Nathan; Tracey Taylor; Elyse Zelunka; Anne Marie Maloney; L Lee Dupuis Journal: Support Care Cancer Date: 2015-09-03 Impact factor: 3.603
Authors: L Lee Dupuis; Xiaomin Lu; Hannah-Rose Mitchell; Lillian Sung; Meenakshi Devidas; Leonard A Mattano; William L Carroll; Naomi Winick; Stephen P Hunger; Kelly W Maloney; Nina S Kadan-Lottick Journal: Cancer Date: 2016-01-15 Impact factor: 6.860